<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Bipolar Disord</journal-id><journal-id journal-id-type="iso-abbrev">Int J Bipolar Disord</journal-id><journal-title-group><journal-title>International Journal of Bipolar Disorders</journal-title></journal-title-group><issn pub-type="epub">2194-7511</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407853</article-id><article-id pub-id-type="pmc">PMC12102454</article-id>
<article-id pub-id-type="publisher-id">388</article-id><article-id pub-id-type="doi">10.1186/s40345-025-00388-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Exploring the temporal relationship between mood, alcohol- and nicotine use in bipolar disorder using time-series analyses</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Glastad</surname><given-names>Stine Holmstul</given-names></name><address><email>s.h.glastad@ous-research.no</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Klungs&#x000f8;yr</surname><given-names>Ole</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Aminoff</surname><given-names>Sofie Ragnhild</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hagen</surname><given-names>Roger</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Bjella</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Engen</surname><given-names>Magnus Johan</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Lyngstad</surname><given-names>Siv Hege</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Busch</surname><given-names>Cecilie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Icick</surname><given-names>Romain</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Etain</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Melle</surname><given-names>Ingrid</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Andreassen</surname><given-names>Ole A.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000f8;egh</surname><given-names>Margrethe Collier</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lagerberg</surname><given-names>Trine Vik</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Section for Clinical Psychosis Research, Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Department for Research and Innovation, Oslo Centre for Biostatistics and Epidemiology, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Department for Research and Innovation, Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xtthb56</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution>Department of Psychology, </institution><institution>University of Oslo, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xg72x27</institution-id><institution-id institution-id-type="GRID">grid.5947.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 1516 2393</institution-id><institution>Department of Psychology, </institution><institution>Norwegian University of Science and Technology, </institution></institution-wrap>Trondheim, Norway </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Section for Treatment Research, Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xtthb56</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution>Institute of Clinical Medicine, </institution><institution>University of Oslo, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>Nydalen District Psychiatric Centre, Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05f82e368</institution-id><institution-id institution-id-type="GRID">grid.508487.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 7885 7602</institution-id><institution>Universit&#x000e9; Paris Cit&#x000e9;, INSERM UMR-S 1144, Optimisation Th&#x000e9;rapeutique en Neuropsychopharmacologie OTeN, </institution></institution-wrap>Paris, France </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01zkyzz15</institution-id><institution-id institution-id-type="GRID">grid.414095.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1797 9913</institution-id><institution>D&#x000e9;partement de Psychiatrie et de M&#x000e9;decine Addictologique, </institution><institution>AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU Neurosciences, H&#x000f4;pital Fernand Widal, </institution></institution-wrap>Paris, France </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xtthb56</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution>Center for Precision Psychiatry, Division of Mental Health and Addiction, </institution><institution>University of Oslo &#x00026; Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>18</elocation-id><history><date date-type="received"><day>3</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>2</day><month>5</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The prevalence of substance use disorders in bipolar disorder (BD) is high. Exploring potential interactions between mood and the use of common substances such as alcohol and nicotine may contribute to a better understanding of the mechanisms underlying such comorbidities. Digital tools now allow for continuous monitoring and data collection of both symptoms and behavior. This enables time-series analyses to explore such associations with greater precision.</p></sec><sec><title>Methods</title><p id="Par2">Thirty-two individuals in the early phases of BD registered their mood daily and their use of substances weekly in the MinDag (MyDay) app for up to 6 months. We explored temporal relationships between the use of alcohol and nicotine and the levels of depressed, elevated, irritable, and anxious mood using Vector Autoregressive Models and Granger causality tests.</p></sec><sec><title>Results</title><p id="Par3">We found indications that mood influenced alcohol- and nicotine use, and vice versa. Significant temporal relationships (Granger causality) were found in 55% (11 out of 20) of the participants for alcohol and 70% (7 out of 10) for nicotine use, and with high proportions of the variance explained by the one time-series on the other. The associations were consistent with causal effects in one or both directions, but with no adjustment for confounding.</p></sec><sec><title>Conclusion</title><p id="Par4">Our findings indicate that mood influences alcohol- and nicotine use and vice versa in individuals with BD, although caution should be taken due to the exploratory approach. Larger samples are needed to further disentangle these relationships to provide insight for better prevention and treatment of BD and comorbid substance use disorders.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bipolar disorder</kwd><kwd>Mood</kwd><kwd>Nicotine use</kwd><kwd>Alcohol use</kwd><kwd>Time-series analyses</kwd><kwd>App monitoring</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100006095</institution-id><institution>Helse S&#x000f8;r-&#x000d8;st RHF</institution></institution-wrap></funding-source><award-id>2007069</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100005416</institution-id><institution>Norges Forskningsr&#x000e5;d</institution></institution-wrap></funding-source><award-id>288542</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par18">Bipolar disorder (BD) is a mental illness characterized by repeated episodes of depression and mania or hypomania. A majority of individuals with BD may spend a considerable amount of time in affective episodes each year, with recurrence rates of both mania and depression averaging approximately one episode per year (Tondo et al. <xref ref-type="bibr" rid="CR35">2017</xref>). Given the recurrent nature of BD, it is vital to identify predictors of affective symptom exacerbations (Grande et al. <xref ref-type="bibr" rid="CR16">2016</xref>).</p><p id="Par19">Excessive use of alcohol is common in individuals with BD (Blanco et al. <xref ref-type="bibr" rid="CR4">2017</xref>), with use often developing into abuse or dependence and with lifetime prevalence rates of 30% for alcohol use disorder (AUD) (Hunt et al. <xref ref-type="bibr" rid="CR19">2016</xref>). For comparison, the mean lifetime prevalence of AUD in the general population is around 9% (Glantz et al. <xref ref-type="bibr" rid="CR13">2020</xref>). Studies indicate that AUD can negatively impact the course of BD with increased episode recurrence and risk of rapid cycling (Rakofsky and Dunlop <xref ref-type="bibr" rid="CR31">2013</xref>), increased risk of suicide attempts and suicidal ideation, as well as worse social functioning (Preuss et al. <xref ref-type="bibr" rid="CR30">2020</xref>). AUD has also been associated with longer time until remission from affective episodes, as well as increased depressive and manic symptoms, comorbid substance use disorder (SUD), and higher impulsiveness and affective lability (Icick et al. <xref ref-type="bibr" rid="CR21">2021</xref>; Lagerberg et al. <xref ref-type="bibr" rid="CR23">2017</xref>; Pinto et al. <xref ref-type="bibr" rid="CR29">2020</xref>). Also, lifetime AUD has been associated with higher levels of depressive symptoms in BD patients (Cardoso et al. <xref ref-type="bibr" rid="CR7">2008</xref>), and in women with BD, increased consumption of alcohol appears to be associated with increases in both depressive and manic symptoms (Gordon-Smith et al. <xref ref-type="bibr" rid="CR15">2020</xref>). However, most research has been conducted on lifetime comorbid AUD so far (Icick et al. <xref ref-type="bibr" rid="CR21">2021</xref>), and little is known about the influence of use that does not meet the criteria for a use disorder on BD symptoms.</p><p id="Par20">With regards to nicotine, the use has been significantly reduced in the general population over the last decades, while this is not the case for individuals with BD (R&#x000f8;devand et al. <xref ref-type="bibr" rid="CR32">2019</xref>). Here, the lifetime prevalence rates are still as high as 46% for tobacco use disorders (TUD)/nicotine dependence (Fornaro et al. <xref ref-type="bibr" rid="CR12">2022</xref>). There are indications from cross-sectional studies that TUD may be associated with more lifetime mood episodes (Gross et al. <xref ref-type="bibr" rid="CR17">2020</xref>), and being a smoker has been associated with having more manic episodes per year of illness (Icick et al. <xref ref-type="bibr" rid="CR20">2017</xref>). There is also an association between smoking and suicide attempts in individuals with BD (Ducasse et al. <xref ref-type="bibr" rid="CR8">2015</xref>).</p><p id="Par21">Given that most studies investigating the relationship between nicotine and alcohol use disorders and the course of BD are cross-sectional, there are still controversies with regards to the putative directions of causality; does substance use cause affective symptoms and syndromes, or does the presence of affective symptoms cause more substance use? Furthermore, existing longitudinal studies of the relationship between substance use and the course of BD have focused mainly on established AUD or SUDs, or have had a large proportion of participants with these disorders in their sample (Baethge et al. <xref ref-type="bibr" rid="CR1">2008</xref>; van Zaane et al. <xref ref-type="bibr" rid="CR36">2014</xref>). However, research focusing on younger samples with shorter BD illness duration and who have not yet developed AUD, is still needed. In a recent study by our group where we focused on non-pathological alcohol- and nicotine use, we found no associations between use of these substances and affective symptoms in individuals with BD without SUDs (Glastad et al. <xref ref-type="bibr" rid="CR14">2023</xref>). However, there may still be individual within-person interplays between the use of alcohol, nicotine and mood symptoms that were not identified due to the cross-sectional design. Smartphone-based collection of day-to-day data could be a way to explore these possible temporal relationships in a more valid and in-depth manner with new statistical methods. Previous longitudinal studies on temporal relationships between affective states and alcohol use have been based on paper-and-pencil methods for self-report and/or low resolution in the time-intervals used to investigate the interplays, both with higher risk for recall bias compared to frequent digital self-report (Baethge et al. <xref ref-type="bibr" rid="CR1">2008</xref>; Faurholt-Jepsen et al. <xref ref-type="bibr" rid="CR9">2016</xref>; van Zaane et al. <xref ref-type="bibr" rid="CR36">2014</xref>).</p><p id="Par22">Both alcohol and nicotine exert immediate rewarding psychological effects through their effects on serotonergic and dopaminergic systems (Singh <xref ref-type="bibr" rid="CR34">2021</xref>; Wittenberg et al. <xref ref-type="bibr" rid="CR38">2020</xref>). Thus, the association between mood symptoms and use of nicotine and alcohol may be understood as substances being used as an attempt to regulate affective states, often called self-medication (Khantzian <xref ref-type="bibr" rid="CR22">1997</xref>). Indeed, results from a systematic review indicated that individuals with BD use alcohol to relieve distressing mood, but also to enhance euphoric mood (McDonald and Meyer <xref ref-type="bibr" rid="CR26">2011</xref>). However, in previous studies participants have been asked whether they use substances to alleviate symptoms, with a potential risk of bias due to a possible rationalization of a stigmatized behavior (Bolton et al. <xref ref-type="bibr" rid="CR5">2009</xref>; Canham et al. <xref ref-type="bibr" rid="CR6">2018</xref>; Pettersen et al. <xref ref-type="bibr" rid="CR27">2013</xref>). To our knowledge, possible self-regulation of BD symptoms with nicotine has previously not been investigated specifically.</p><p id="Par23">In this study, we will investigate the temporal relationship between changes in mood (i.e. levels of mood elevation, irritability, sadness, and anxiety) and alcohol- and nicotine use over time through time-series analyses of data from app-based self-monitoring in individuals with BD. The aim is to explore whether changes in mood are followed by changes in alcohol- or nicotine use, and vice versa. We also investigate whether putative temporal relationships between alcohol use and mood differ between individuals with and without AUD, and/or the use of other substances. Since the statistical approach we have applied should be considered exploratory, we do not put forward any clear hypotheses.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Participants</title><p id="Par24">The study was conducted at the NORMENT centre (Norwegian Center for Mental Disorders Research) at Oslo University Hospital (OUS) in Oslo, Norway. The participants were recruited from the Bipolar Unit at Nydalen District Psychiatric Center (OUS). This is a catchment-area-based, out-patient specialized care unit providing treatment for patients in the early course of BD. The catchment-area represents all social strata. Inclusion criteria for participation in the current study were a diagnosis of BD type I, II or NOS (not otherwise specified), age between 18 and 65&#x000a0;years and willingness to use the MinDag (My Day) app to self-report mood and substance use for up to 6 months. Exclusion criteria were lack of understanding of a Scandinavian language. The total sample comprised 32 participants: 12 with BD I, 17 with BD II, and 3 with BD NOS.</p></sec><sec id="Sec4"><title>Diagnostic evaluations</title><p id="Par25">Diagnostic evaluations were conducted by a medical doctor, psychiatrist, or clinical psychologist using the Structured Clinical Interview for DSM-IV axis I disorders (SCID) modules A-E or the SCID-5 Clinicians&#x02019; Version (CV). Since the DSM-5 CV only covers current disorders, the lifetime substance use disorder module of SCID-5 Research Version was added for the purpose of the study (First <xref ref-type="bibr" rid="CR11">2002</xref>; First et al. <xref ref-type="bibr" rid="CR10">2016</xref>). Diagnoses were systematically discussed in consensus meetings in the presence of experienced clinical specialists/PhDs in psychiatry and psychology.</p></sec><sec id="Sec5"><title>App-based longitudinal self-report with MinDag</title><p id="Par26">The MinDag app was developed by researchers at the NORMENT centre in collaboration with the Center for Information Technology at the University of Oslo (Bjella et al. <xref ref-type="bibr" rid="CR3">2022</xref>). MinDag comprises six modules, and data from two of them were used for the purpose of the current study. The MinDag mood section consists of an adapted version of a subscale of the Multidimensional Assessment of Thymic States (MAThyS) with 7 items covering happiness, sadness, anger, irritability, mood elevation, anxiety and panic. The items are rated on a 7- point Likert scale from &#x0201c;not at all&#x0201d; to &#x0201c;to a large degree&#x0201d; (Henry et al. <xref ref-type="bibr" rid="CR18">2008</xref>), where higher scores indicate higher levels of the respective emotional states. Participants are prompted by the app to rate all mood items on a daily basis. In this study we focused on sadness, mood elevation and irritability as they represent the core mood features of BD, along with anxiety, which is a common comorbid symptom in BD.</p><p id="Par27">Also, once a week, the participants were prompted by the app to register their use of alcohol, nicotine, and other substances:</p><p id="Par28">1) Nicotine (cigarettes, &#x0201c;snus&#x0201d; (in Scandinavia a legal smokeless tobacco), and e-cigarettes): If the participants indicated that they had used nicotine, they were asked how many units of nicotine they had used on average each day during the last week. It was possible to register use of all three nicotine types during 1 week.</p><p id="Par29">2) Alcohol: If the participants indicated that they had used alcohol, they were asked to report how many days during the last week they had been drinking, and how many units they had consumed of either wine, beer or drinks in total during the last week.</p><p id="Par30">3) Other substances: If the participants indicated that they had used any of the following substances during the last week: hashish/marihuana, amphetamine/methamphetamine, cocaine, heroin, GHB/GBL, anabolic steroids, hallucinogens, or unprescribed medications, they were asked to report how many days they had used each substance during the last week.</p></sec><sec id="Sec6"><title>App-based data completeness and imputation</title><p id="Par31">The participants were asked to use the app for 6 months but were informed that shorter periods were also valuable and acceptable. Cases were excluded from the analyses if they had registered data only for a period of 2 weeks or less. This was the case for nine participants, reducing the sample from N&#x02009;=&#x02009;41 to N&#x02009;=&#x02009;32. In this final sample, the range of weekly registrations per participant was 7&#x02013;27&#x000a0;weeks, with a mean of 18.3&#x000a0;weeks. To synchronize mood and substance use intervals to enable time-series modelling, we calculated the weekly mean scores for the four mood variables, which in some cases were based on less than seven days due to sporadically missing data. If relevant data (alcohol, nicotine, or mood registrations) was missing at the start or the end of a time-series, the series was shortened accordingly. In cases of missing data in a time-series, which was the case in 102 out of a total of 633&#x000a0;weeks across the whole data set, values were imputed by the mean of the preceding and subsequent value of the time-series. After the imputation, the total number of weeks used in the analyses was 587. The proportion of missing data was thus 16.1%.</p></sec><sec id="Sec7"><title>Statistical analyses</title><p id="Par32">The statistical analyses were conducted with the IBM Statistical Package for Social Sciences version 29 and R. A Vector Autoregression Model (VAR) was used for multivariate time-series modelling of the pairwise relationships between mood (any of the four mood items) and alcohol and mood and nicotine, implemented in the R-package <italic>vars</italic> (L&#x000fc;tkepohl <xref ref-type="bibr" rid="CR25">2005</xref>; Pfaff <xref ref-type="bibr" rid="CR28">2008</xref>). Although VAR models and time-series analyses have previously been used to investigate behavioral within-person relationships (Lorenz et al. <xref ref-type="bibr" rid="CR24">2020</xref>), the approach should be considered explorative and mainly as a means of generating hypotheses. In such a model, each variable is regressed on time-lagged values of itself and time-lagged values of other variables. Ordinary least squares (OLS) is used for parameter-estimation. To investigate stationarity, i.e. that the time-series&#x02019; statistical properties such as mean and variance remain constant over time, we used the Dicky-Fuller augmented test (Banerjee <xref ref-type="bibr" rid="CR2">1993</xref>; Said and Dickey <xref ref-type="bibr" rid="CR33">1984</xref>). A potential causal relationship was assessed by means of testing for &#x0201c;Granger-causality&#x0201d; (<italic>vars</italic>). One time-series <inline-formula id="IEq1"><alternatives><tex-math id="d33e602">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{1,t}$$\end{document}</tex-math><mml:math id="d33e607"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq1.gif"/></alternatives></inline-formula> is said to Granger-cause another time-series <inline-formula id="IEq2"><alternatives><tex-math id="d33e616">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{2,t}$$\end{document}</tex-math><mml:math id="d33e621"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq2.gif"/></alternatives></inline-formula> if predictions of <inline-formula id="IEq3"><alternatives><tex-math id="d33e630">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{2,t}$$\end{document}</tex-math><mml:math id="d33e635"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq2.gif"/></alternatives></inline-formula> based on its own history and past values of <inline-formula id="IEq4"><alternatives><tex-math id="d33e644">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{1,t}$$\end{document}</tex-math><mml:math id="d33e649"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq1.gif"/></alternatives></inline-formula> are better than predictions of <inline-formula id="IEq5"><alternatives><tex-math id="d33e659">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{2,t}$$\end{document}</tex-math><mml:math id="d33e664"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq2.gif"/></alternatives></inline-formula> based only on its own past values. As the study was explorative, i.e. with the aim to detect any potential temporal relationships between alcohol or nicotine and mood, we applied a p-value threshold for significant Granger-causality of p&#x02009;&#x02264;&#x02009;0.1.</p><p id="Par33">Pairwise VAR models were fitted, one with different mood variables (one at a time) and number of alcohol units (transformed), and another with different mood variables and number of nicotine units. Two lags were included for a flexible model, and to limit the number of parameters. Each VAR model can be expressed as:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="d33e675">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} {y}_{1,t}&#x00026;={\alpha }_{0}+{\alpha }_{1}{y}_{1,t-1}+{\alpha }_{2}{y}_{1,t-2}+{\alpha }_{3}{y}_{2,t-1}+{\alpha }_{4}{y}_{2,t-2}+{\varepsilon }_{1,t} \\ {y}_{2,t}&#x00026;={\beta }_{0}+{\beta }_{1}{y}_{1,t-1}+{\beta }_{2}{y}_{1,t-2}+{\beta }_{3}{y}_{2,t-1}+{\beta }_{4}{y}_{2,t-2}+{\varepsilon }_{2,t} \end{aligned}$$\end{document}</tex-math><mml:math id="d33e681" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd columnalign="right"><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mrow/><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b2;</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b5;</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="40345_2025_388_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par34">In case of non-stationarity, a time series with the differences between the lagged values was formed (<inline-formula id="IEq6"><alternatives><tex-math id="d33e829">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${D}_{1,t}={y}_{1,t+1}-{y}_{1,t}$$\end{document}</tex-math><mml:math id="d33e834"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="40345_2025_388_Article_IEq6.gif"/></alternatives></inline-formula>) and used instead (iterated if the difference series was non-stationary). Impulse response and forecast error variance decomposition (FEVD) was calculated to assess the impact of one time-series on the other (<italic>vars</italic>). The impulse response illustrates how the dynamic system reacts to a &#x0201c;shock&#x0201d; (equal to 1 standard deviation (Std)) in one of the error terms, and can be used to interpret the impact of e.g. mood variables on alcohol use, or vice versa. This is represented by a plot of the forecast of each variable in the fitted model with corresponding bootstrapped 95% confidence intervals. The FEVD expresses how much of the forecast (prediction) error in one series, for a certain number of steps ahead, that can be attributed to the other series. A simple interpretation is that it corresponds to the proportion of explained variance due to the other series.</p><p id="Par35">A separate VAR model was fitted for each participant. Inference across participants was therefore a challenge. The total number of VAR models were summarized to compare participants descriptively without testing and should be viewed as exploratory analyses. One participant had a stationary time-series, but the analyses yielded non-valid results and was therefore not included.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Demographics and clinical characteristics</title><p id="Par36">The demographic and clinical characteristics of the total sample are presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The number of units used of alcohol and nicotine are based on app-based self-report and presented for participants who reported any use of the specific substance: 32 (100%) for alcohol and 19 (59.4%) for nicotine.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Demographic and clinical characteristics of the sample (N&#x02009;=&#x02009;32)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left">Total</th></tr></thead><tbody><tr><td align="left">Female sex, <italic>n</italic> (%)</td><td align="left">19 (59.4)</td></tr><tr><td align="left">Age, years, mean (Std)</td><td align="left">33.28 (10.1)</td></tr><tr><td align="left">Range, years</td><td align="left">21&#x02013;57</td></tr><tr><td align="left">Data collection period, weeks, mean (Std)</td><td align="left">18.3 (6.24)</td></tr><tr><td align="left">Range, weeks</td><td align="left">7&#x02013;27</td></tr><tr><td align="left">Missing data, weeks (%)</td><td align="left">102 (16.1)</td></tr><tr><td align="left">BD subtype, <italic>n</italic> (%)</td><td align="left"/></tr><tr><td align="left">BD I</td><td align="left">12 (37.5)</td></tr><tr><td align="left">BD II</td><td align="left">17 (53.1)</td></tr><tr><td align="left">BD NOS</td><td align="left">3 (9.4)</td></tr><tr><td align="left">Comorbid disorders,<italic> n</italic> (%)</td><td align="left">13 (40.6)</td></tr><tr><td align="left">Alcohol use disorder, current, <italic>n</italic> (%)</td><td align="left">2 (6.3)</td></tr><tr><td align="left">Alcohol use disorder, lifetime (%)</td><td align="left">2 (6.3)</td></tr><tr><td align="left">Illicit<sup>a</sup> substance use disorder, current,<italic> n</italic> (%)</td><td align="left">1 (3.1)</td></tr><tr><td align="left">Illicit<sup>a</sup> substance use disorder, lifetime,<italic> n</italic> (%)</td><td align="left">2 (6.3)</td></tr><tr><td align="left">Anxiety disorder<sup>b</sup>,<italic> n</italic> (%)</td><td align="left">8 (25.0)</td></tr><tr><td align="left">Nicotine use, <italic>n</italic> (%)</td><td align="left">19 (59.4)</td></tr><tr><td align="left">Nicotine units per week, mean (Std)</td><td align="left">9.64 (10.3)</td></tr><tr><td align="left">Range, units per week</td><td align="left">0&#x02013;130</td></tr><tr><td align="left">Alcohol use, <italic>n</italic> (%)</td><td align="left">32 (100)</td></tr><tr><td align="left">Alcohol units per week, mean (Std)</td><td align="left">7.45 (8.2)</td></tr><tr><td align="left">Range, units per week</td><td align="left">0&#x02013;44</td></tr><tr><td align="left">Any illicit substance use, <italic>n</italic> (%)</td><td align="left">5 (15.6)</td></tr></tbody></table><table-wrap-foot><p>BD: Bipolar Disorder, Std: Standard Deviation; <sup>a</sup>includes the following Use Disorders; Cannabis, Cocaine, MDMA, and Hallucinogens. <sup>b</sup>includes Social Phobia, Generalized Anxiety Disorder, Panic Disorder, Agoraphobia and Post Traumatic Stress Disorder</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Alcohol (transformed) and mood</title><p id="Par37">Twenty participants (62.5%) of those who reported alcohol use had stationary alcohol series, and all of these had at least one stationary mood series. Of these 20, 11 (55%) had Granger causality tests representing significant effects in one or both directions between a mood variable and alcohol use (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Significant Granger causality between mood and alcohol units per week (transformed with square root)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Mood</th><th align="left">Number of participants</th></tr></thead><tbody><tr><td align="left">&#x000a0;Mood&#x02009;&#x02192;&#x02009;Alcohol</td><td align="left">6 (id: 5, 14, 20, 30, 31, 36)</td></tr><tr><td align="left">&#x000a0;Alcohol&#x02009;&#x02192;&#x02009;Mood</td><td align="left">3 (id: 2, 13, 27)</td></tr><tr><td align="left">&#x000a0;Mood&#x02009;&#x02194;&#x02009;Alcohol</td><td align="left">2 (id: 22, 25)</td></tr></tbody></table></table-wrap></p><p id="Par38">One of the participants with stationary alcohol series had a current AUD. The time-series of this participant showed a significant Granger-causal relationship from alcohol use to mood. Two participants with stationary time-series had previous SUDs involving several other substances than alcohol and nicotine. Both had significant Granger causality between mood and both alcohol- and nicotine use. Furthermore, four participants, all with stationary time-series on either alcohol use, nicotine use, or both, reported use of other substances during the study period. Only one of them, the same participant who also had an AUD, had a significant Granger-causal relationship from alcohol use to mood. Of the five participants who had a previous SUD involving other substances or a current or previous AUD, only one reported use of other substances during the study period.</p><p id="Par39">For illustration, the raw time-series data for participant with ID&#x02009;=&#x02009;25 is plotted in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a, with alcohol use (units per week, square root transformed) as the solid line, and mean sadness per week as the dotted line.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p><bold>a</bold> Time course of alcohol units per week (transformed) and sadness for ID&#x02009;=&#x02009;25. Alcohol use&#x02009;=&#x02009;Number of alcohol units, square root transformed. <bold>b</bold> Impulse response function in sadness, from a &#x0201c;shock&#x0201d; (=&#x02009;1 Std) in alcohol units, ID&#x02009;=&#x02009;25. The red dotted lines represent 95% bootstrap confidence intervals, with 200 runs" should be placed under Figure 1b</p></caption><graphic xlink:href="40345_2025_388_Fig1_HTML" id="MO1"/></fig></p><p id="Par40">For this participant, alcohol use was shown to significantly Granger cause sadness, which was supported by the impulse response function (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). A sudden short-term increase (&#x0201c;shock&#x0201d;) in alcohol use led to a significant long-term increase in sadness with the 95% bootstrap confidence interval not covering 0 from three to nine weeks. Furthermore, the variance decomposition showed that a large amount of the variation in mood, in this case sadness, was explained by alcohol use (as shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). A maximum of 23% of the variance in this participants sadness was explained by alcohol consumption, over a period of 10&#x000a0;weeks.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Forecast error variance decomposition (FEVD) for participants with significant Granger causality between mood and alcohol use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Granger Causality</th><th align="left">Lag 1<sup>a</sup></th><th align="left">Lag 2</th><th align="left">Lag 3</th><th align="left">Lag 4</th><th align="left">Lag 5</th><th align="left">Lag 6</th><th align="left">Lag 7</th><th align="left">Lag 8</th><th align="left">Lag 9</th><th align="left">Lag 10</th><th align="left">p-value</th></tr></thead><tbody><tr><td align="left" colspan="11">Mood Granger causes alcohol use</td><td char="." align="char"/></tr><tr><td align="left">&#x000a0;ID 5</td><td char="." align="char">0.02</td><td char="." align="char">0.01</td><td char="." align="char">0.14</td><td char="." align="char">0.11</td><td char="." align="char">0.15</td><td char="." align="char">0.12</td><td char="." align="char">0.13</td><td char="." align="char">0.12</td><td char="." align="char">0.12</td><td char="." align="char">0.11</td><td align="left">.014</td></tr><tr><td align="left">&#x000a0;ID 14</td><td char="." align="char">0.01</td><td char="." align="char">0.03</td><td char="." align="char">0.22</td><td char="." align="char">0.27</td><td char="." align="char">0.28</td><td char="." align="char">0.34</td><td char="." align="char">0.36</td><td char="." align="char">0.36</td><td char="." align="char">0.37</td><td char="." align="char">0.38</td><td align="left">.003</td></tr><tr><td align="left">&#x000a0;ID 20</td><td char="." align="char">0.02</td><td char="." align="char">0.24</td><td char="." align="char">0.34</td><td char="." align="char">0.32</td><td char="." align="char">0.32</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td align="left">.009</td></tr><tr><td align="left">&#x000a0;ID 22<sup>*</sup></td><td char="." align="char">0.05</td><td char="." align="char">0.08</td><td char="." align="char">0.31</td><td char="." align="char">0.36</td><td char="." align="char">0.36</td><td char="." align="char">0.37</td><td char="." align="char">0.37</td><td char="." align="char">0.39</td><td char="." align="char">0.39</td><td char="." align="char">0.39</td><td align="left">.043</td></tr><tr><td align="left">&#x000a0;ID 25<sup>*</sup></td><td char="." align="char">0.01</td><td char="." align="char">0.06</td><td char="." align="char">0.10</td><td char="." align="char">0.12</td><td char="." align="char">0.13</td><td char="." align="char">0.14</td><td char="." align="char">0.14</td><td char="." align="char">0.15</td><td char="." align="char">0.15</td><td char="." align="char">0.15</td><td align="left">.002</td></tr><tr><td align="left">&#x000a0;ID 30</td><td char="." align="char">0.04</td><td char="." align="char">0.16</td><td char="." align="char">0.35</td><td char="." align="char">0.43</td><td char="." align="char">0.43</td><td char="." align="char">0.43</td><td char="." align="char">0.44</td><td char="." align="char">0.44</td><td char="." align="char">0.44</td><td char="." align="char">0.44</td><td align="left">.048</td></tr><tr><td align="left">&#x000a0;ID 31</td><td char="." align="char">0.04</td><td char="." align="char">0.06</td><td char="." align="char">0.18</td><td char="." align="char">0.16</td><td char="." align="char">0.15</td><td char="." align="char">0.16</td><td char="." align="char">0.16</td><td char="." align="char">0.16</td><td char="." align="char">0.16</td><td char="." align="char">0.15</td><td align="left">.022</td></tr><tr><td align="left">&#x000a0;ID 36</td><td char="." align="char">0.03</td><td char="." align="char">0.33</td><td char="." align="char">0.32</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td char="." align="char">0.36</td><td char="." align="char">0.36</td><td char="." align="char">0.37</td><td char="." align="char">0.37</td><td char="." align="char">0.38</td><td align="left">.001</td></tr><tr><td align="left">&#x000a0;Mean</td><td char="." align="char">0.03</td><td char="." align="char">0.12</td><td char="." align="char">0.25</td><td char="." align="char">0.26</td><td char="." align="char">0.27</td><td char="." align="char">0.28</td><td char="." align="char">0.29</td><td char="." align="char">0.29</td><td char="." align="char">0.29</td><td char="." align="char">0.29</td><td align="left"/></tr><tr><td align="left" colspan="11">Alcohol use Granger causes mood</td><td char="." align="char"/></tr><tr><td align="left">&#x000a0;ID 2</td><td char="." align="char">0.00</td><td char="." align="char">0.18</td><td char="." align="char">0.32</td><td char="." align="char">0.32</td><td char="." align="char">0.32</td><td char="." align="char">0.32</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td align="left">.017</td></tr><tr><td align="left">&#x000a0;ID 13</td><td char="." align="char">0.00</td><td char="." align="char">0.06</td><td char="." align="char">0.06</td><td char="." align="char">0.07</td><td char="." align="char">0.06</td><td char="." align="char">0.06</td><td char="." align="char">0.06</td><td char="." align="char">0.06</td><td char="." align="char">0.05</td><td char="." align="char">0.05</td><td align="left">.091</td></tr><tr><td align="left">&#x000a0;ID 22<sup>*</sup></td><td char="." align="char">0.00</td><td char="." align="char">0.03</td><td char="." align="char">0.31</td><td char="." align="char">0.42</td><td char="." align="char">0.42</td><td char="." align="char">0.48</td><td char="." align="char">0.49</td><td char="." align="char">0.49</td><td char="." align="char">0.50</td><td char="." align="char">0.51</td><td align="left">.015</td></tr><tr><td align="left">&#x000a0;ID 25<sup>*</sup></td><td char="." align="char">0.00</td><td char="." align="char">0.02</td><td char="." align="char">0.15</td><td char="." align="char">0.20</td><td char="." align="char">0.21</td><td char="." align="char">0.22</td><td char="." align="char">0.22</td><td char="." align="char">0.23</td><td char="." align="char">0.23</td><td char="." align="char">0.23</td><td align="left">.028</td></tr><tr><td align="left">&#x000a0;ID 27</td><td char="." align="char">0.00</td><td char="." align="char">0.01</td><td char="." align="char">0.15</td><td char="." align="char">0.26</td><td char="." align="char">0.30</td><td char="." align="char">0.29</td><td char="." align="char">0.29</td><td char="." align="char">0.30</td><td char="." align="char">0.30</td><td char="." align="char">0.29</td><td align="left">.054</td></tr><tr><td align="left">Mean</td><td char="." align="char">0.00</td><td char="." align="char">0.06</td><td char="." align="char">0.20</td><td char="." align="char">0.25</td><td char="." align="char">0.26</td><td char="." align="char">0.27</td><td char="." align="char">0.28</td><td char="." align="char">0.28</td><td char="." align="char">0.28</td><td char="." align="char">0.28</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>The table shows significant Granger causality between mood and alcohol use over a period of ten weeks. For patients with significant Granger causality between more than one Mood variable, only one of the FEVDs is presented. A simple interpretation of the FEVD is that it corresponds to the proportion of explained variance due to the other time-series. <sup>a</sup>Lag numbers correspond to weeks, <sup>*</sup>The participant has a bidirectional relationship</p></table-wrap-foot></table-wrap></p><p id="Par41">Table <xref rid="Tab3" ref-type="table">3</xref> shows the forecast error variance decomposition (FEVD) for participants with significant Granger causality between mood and alcohol use. Averaged over the eight participants with significant effects in the same direction i.e. mood to alcohol including the participants with a bidirectional relationship, 29% of the variance, i.e. forecast error variance decomposition as a function of time, in alcohol was explained by a mood variable at 10&#x000a0;weeks, with a range from 11 to 44%. For the five participants with significant effects from alcohol to mood including the participants with a bidirectional relationship, 28% of the variance in mood was explained by alcohol at 10&#x000a0;weeks, with a range from 5 to 51%.</p></sec><sec id="Sec11"><title>Nicotine units (cigarettes, snus) and mood</title><p id="Par42">Ten participants (53%) of those who reported nicotine use, had stationary time series of nicotine use, and of these, seven (70%) had significant tests for Granger causality in one or both directions between nicotine use and mood (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Significant Granger causality between mood and nicotine units per week by identification number</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Mood</th><th align="left">Number of participants</th></tr></thead><tbody><tr><td align="left">Mood&#x02009;&#x02192;&#x02009;Nicotine</td><td align="left">4 (id: 2, 12, 31, 36)</td></tr><tr><td align="left">Nicotine&#x02009;&#x02192;&#x02009;Mood</td><td align="left">3 (id: 5, 22, 25)</td></tr><tr><td align="left">Mood&#x02009;&#x02194;&#x02009;Nicotine</td><td align="left">0</td></tr></tbody></table></table-wrap></p><p id="Par43">For illustration, the raw time series for anxiety and total number of nicotine units per week for participant with ID&#x02009;=&#x02009;36 is shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p><bold>a</bold> Time course of nicotine units per week and anxiety for ID&#x02009;=&#x02009;36. <bold>b</bold> Impulse response function in nicotine units, from a &#x0201c;shock&#x0201d; (=&#x02009;1 Std) in anxiety, ID&#x02009;=&#x02009;36. The red dotted lines represent 95% bootstrap confidence intervals, with 200 runs</p></caption><graphic xlink:href="40345_2025_388_Fig2_HTML" id="MO2"/></fig></p><p id="Par44">Anxiety was found to significantly Granger cause nicotine use, and this was supported in the impulse response function (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b). A &#x0201c;shock&#x0201d; in anxiety led to a significant short-lived change in nicotine that disappeared after 3 weeks. Nicotine use explained a maximum of 65% of the variance in mood over a period of 10&#x000a0;weeks (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Forecast error variance decomposition (FEVD) for patients with significant Granger causality between mood and nicotine use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Granger Causality</th><th align="left">Lag 1<sup>a</sup></th><th align="left">Lag 2</th><th align="left">Lag 3</th><th align="left">Lag 4</th><th align="left">Lag 5</th><th align="left">Lag 6</th><th align="left">Lag 7</th><th align="left">Lag 8</th><th align="left">Lag 9</th><th align="left">Lag 10</th><th align="left">p-value</th></tr></thead><tbody><tr><td align="left" colspan="11">Mood Granger causes nicotine use</td><td char="." align="char"/></tr><tr><td align="left">&#x000a0;ID 2</td><td char="." align="char">0.01</td><td char="." align="char">0.01</td><td char="." align="char">0.13</td><td char="." align="char">0.23</td><td char="." align="char">0.24</td><td char="." align="char">0.25</td><td char="." align="char">0.27</td><td char="." align="char">0.27</td><td char="." align="char">0.27</td><td char="." align="char">0.27</td><td align="left">.028</td></tr><tr><td align="left">&#x000a0;ID 12</td><td char="." align="char">0.16</td><td char="." align="char">0.18</td><td char="." align="char">0.29</td><td char="." align="char">0.30</td><td char="." align="char">0.31</td><td char="." align="char">0.31</td><td char="." align="char">0.31</td><td char="." align="char">0.31</td><td char="." align="char">0.31</td><td char="." align="char">0.31</td><td align="left">.080</td></tr><tr><td align="left">&#x000a0;ID 31</td><td char="." align="char">0.08</td><td char="." align="char">0.19</td><td char="." align="char">0.14</td><td char="." align="char">0.13</td><td char="." align="char">0.14</td><td char="." align="char">0.13</td><td char="." align="char">0.14</td><td char="." align="char">0.13</td><td char="." align="char">0.13</td><td char="." align="char">0.13</td><td align="left">.051</td></tr><tr><td align="left">&#x000a0;ID 36</td><td char="." align="char">0.26</td><td char="." align="char">0.57</td><td char="." align="char">0.64</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td char="." align="char">0.65</td><td align="left">.016</td></tr><tr><td align="left">&#x000a0;Mean</td><td char="." align="char">0.13</td><td char="." align="char">0.24</td><td char="." align="char">0.30</td><td char="." align="char">0.33</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td char="." align="char">0.34</td><td align="left"/></tr><tr><td align="left" colspan="11">Nicotine use Granger causes mood</td><td char="." align="char"/></tr><tr><td align="left"> ID 5</td><td char="." align="char">0.00</td><td char="." align="char">0.12</td><td char="." align="char">0.40</td><td char="." align="char">0.43</td><td char="." align="char">0.45</td><td char="." align="char">0.48</td><td char="." align="char">0.48</td><td char="." align="char">0.48</td><td char="." align="char">0.48</td><td char="." align="char">0.48</td><td align="left">.032</td></tr><tr><td align="left">&#x000a0;ID 22</td><td char="." align="char">0.00</td><td char="." align="char">0.07</td><td char="." align="char">0.21</td><td char="." align="char">0.33</td><td char="." align="char">0.39</td><td char="." align="char">0.41</td><td char="." align="char">0.41</td><td char="." align="char">0.41</td><td char="." align="char">0.41</td><td char="." align="char">0.41</td><td align="left">.077</td></tr><tr><td align="left">&#x000a0;ID 25</td><td char="." align="char">0.00</td><td char="." align="char">0.02</td><td char="." align="char">0.08</td><td char="." align="char">0.08</td><td char="." align="char">0.08</td><td char="." align="char">0.09</td><td char="." align="char">0.09</td><td char="." align="char">0.09</td><td char="." align="char">0.09</td><td char="." align="char">0.09</td><td align="left">.097</td></tr><tr><td align="left">&#x000a0;Mean</td><td char="." align="char">0.00</td><td char="." align="char">0.07</td><td char="." align="char">0.23</td><td char="." align="char">0.28</td><td char="." align="char">0.31</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td char="." align="char">0.33</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>The table shows significant Granger causality between mood and nicotine use over a period of ten weeks. A simple interpretation of the FEVD is that it corresponds to the proportion of explained variance due to the other time-series. <sup>a</sup>Lag numbers correspond to weeks</p></table-wrap-foot></table-wrap></p><p id="Par45">Averaged over the four participants with significant effects from mood to nicotine use, 34% of the variance in nicotine use was explained by mood at 10&#x000a0;weeks, ranging from 13 to 65%. Averaged over the three participants with significant effects from nicotine use to mood, 33% of the variance in mood was explained by nicotine use at 10&#x000a0;weeks, ranging from 9 to 48%.</p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par46">In this study, we examined temporal relationships between weekly self-reported mood and alcohol- and nicotine use in a sample of individuals with BD. We found associations between mood and subsequent alcohol- and nicotine use and vice versa. Significant temporal relationships (Granger causality) was found in 55% (11 out of 20) of the participants for alcohol use and 70% (7 out of 10) for nicotine use. The results also indicate that a high proportion of the variance in one variable, e.g. nicotine use, was explained by the other variable, e.g. mood. The associations were consistent with causal effects in one or both directions, although this should be interpreted with caution as the analyses are exploratory. To our knowledge, this is the first published study to date to explore the temporal relationship between nicotine use and mood in BD using app-based longitudinal self-report.</p><p id="Par47">We identified several cases where a change in mood appeared to influence alcohol use during the subsequent weeks and found that a substantial proportion (29%) of the variance in alcohol use was explained by a change in mood. This could suggest that some individuals with BD self-regulate, i.e. attempt to alleviate mood symptoms by increasing their alcohol intake. This is in line with a previous study reporting that poorer emotional self-regulation is associated with increased risk of alcohol- and other substance use disorders in individuals with BD (Wilens et al. <xref ref-type="bibr" rid="CR37">2013</xref>). Other studies investigating whether individuals with BD use substances to alleviate mood symptoms have mainly asked the patients directly about this relationship (Bolton et al. <xref ref-type="bibr" rid="CR5">2009</xref>; Canham et al. <xref ref-type="bibr" rid="CR6">2018</xref>). With this methodology there is considerable risk of response bias due to the tendency to rationalize stigmatized behavior. Although still not eliminated, this risk is likely to be reduced when substance use and mood are independently reported in parallel over time.</p><p id="Par48">We also found that in some cases, changes in alcohol use appeared to have a long-term influence on mood. For instance, as in one participant, a sudden change in alcohol use was followed by a significant change in sadness that persisted for several weeks. Although there were cases where changes in alcohol use were followed by changes in mood, these were of somewhat lower frequency compared to cases where mood appeared to influence alcohol use. As with the opposite relationship, a relatively large proportion of the variance in mood was explained by a preceding change in alcohol use. Although speculative, one may hypothesize that a subgroup of individuals with BD are particularly sensitive to the effects of alcohol on mood. This contrasts the results from our previous study where no significant associations between the levels of alcohol- or nicotine use and the levels of manic- or depressive symptoms were found (Glastad et al. <xref ref-type="bibr" rid="CR14">2023</xref>). Although the study had a large and representative sample size, it was cross-sectional in design and thus interactions over time could not be explored. The results from the current study also contrasts a previous study where the effects of alcohol use on changes in affective states were limited but mainly related to more euthymia (van Zaane et al. <xref ref-type="bibr" rid="CR36">2014</xref>). This study is, however, not directly comparable to the current, as it investigated transitions between affective states, i.e. depression, euthymia etc., and not changes in mood states independently from affective syndromes, as in our study. Our current findings may, however, be more in line with a few previous studies indicating that alcohol use and AUD increase the risk of both affective symptoms and episodes (Cardoso et al. <xref ref-type="bibr" rid="CR7">2008</xref>; Gordon-Smith et al. <xref ref-type="bibr" rid="CR15">2020</xref>).</p><p id="Par49">Two cases showed a bidirectional relationship between mood and use of alcohol. Possibly, in some cases, the relationship between mood and alcohol use may be mutually reinforcing, causing a vicious circle of escalating mood disturbance and alcohol use over time. Such mechanisms may contribute both to the high risk of AUD in BD and to the more destabilized illness course commonly seen in BD with comorbid AUD (Rakofsky and Dunlop <xref ref-type="bibr" rid="CR31">2013</xref>).</p><p id="Par50">As there was only one participant in our sample with a current AUD who presented with significant temporal relationships from alcohol use to mood, comparison with non-AUD participants was not justified. Four participants reported use of other substances than alcohol and nicotine during the study period, all of which had time-series that were amenable to analysis on either alcohol use, nicotine use, or both. Only one of these participants, the same who had an AUD, had a significant temporal relationship from alcohol use to mood. Further studies on larger samples are needed to investigate interactions between mood and substance use across relevant subgroups, including individuals with current and remitted SUDs. Such knowledge may shed light on differences in mechanisms between those who succeed in recovering from their SUD and those who continue their use.</p><p id="Par51">We found that changes in mood was followed by changes in the level of nicotine use in some participants. Further, changes in mood appeared to have a long-term influence on nicotine use in some cases, and a substantial proportion of the variance (34%) in nicotine use was explained by a change in mood. Thus, our findings may indicate that nicotine is being used to self-regulate mood by some individuals with BD, in line with a study reporting a relationship between deficits in emotional self-regulation and nicotine use in individuals with BD (Wilens et al. <xref ref-type="bibr" rid="CR37">2013</xref>). Of note, we also found the opposite relationship, namely that changes in nicotine use in some cases were followed by changes in mood.</p><p id="Par52">Except from our own previous cross-sectional study, where no associations between nicotine use and affective symptoms were found (Glastad et al. <xref ref-type="bibr" rid="CR14">2023</xref>), we are not aware of any other studies on BD where the temporal relationship between mood and nicotine use has been explored. Our preliminary findings, taken together with findings from previous cross-sectional studies where nicotine use has been associated with more manic episodes per year of illness (Icick et al. <xref ref-type="bibr" rid="CR20">2017</xref>), lifetime mood episodes (Gross et al. <xref ref-type="bibr" rid="CR17">2020</xref>), and suicide attempts (Ducasse et al. <xref ref-type="bibr" rid="CR8">2015</xref>), indicate that nicotine use may be of relevance for mood and mood regulation in BD. Thus, further longitudinal studies should investigate the impact of nicotine use on mood, and vice versa, in BD. Future research should include longitudinal neuroimaging studies investigating the impact of nicotine on brain activity in regions related to mood. Furthermore, investigating whether specific genes or epigenetic modifications make individuals with BD more susceptible to nicotine dependence, or influence how nicotine affects mood, are important future avenues. A better understanding of these mechanisms could pave the way for more efficient interventions targeting nicotine use in BD, which although speculative, may also be beneficial for the course of the BD itself.</p><p id="Par53">The use of alcohol and nicotine was relatively low in the current sample. Still, a fairly large number of cases presented with significant relationships between mood and alcohol- and/or nicotine use. Again, with the necessary interpretative precautions, this may indicate that even smaller amounts or changes in use of these substances can influence mood or vice versa.</p></sec><sec id="Sec13"><title>Limitations and strengths</title><p id="Par54">The current study is explorative and although several significant temporal relationships between the variables of interest were found, they should be interpreted with caution. The main limitation of the current study was the small sample size, which prevented subgroup analyses with different levels and patterns of substance use. The small sample size was in part a consequence of the requirement of stationarity in the data of VAR analyses. Still, most cases met the requirements after differencing the series and could be kept in the analyses. Despite the limited sample size, several significant relationships were identified, although we were not able to differentiate between specific mood items. This would have been of interest and should be explored in future studies. Also, we did not have information about whether the participants experienced affective episodes during the registration period. Furthermore, the level of missing data was sub-optimal, and imputation was necessary to enable VAR analyses, with potential risks of inducing bias in the data. However, the proportion of missing data was comparable to other studies based on digital self-monitoring (Faurholt-Jepsen et al. <xref ref-type="bibr" rid="CR9">2016</xref>). Also, nicotine use was relatively low and stable across most of the time series, while alcohol use had a more varied pattern. In addition, we applied a liberal threshold for statistical significance and performed many statistical tests without correcting for multiple testing. This was still considered an adequate approach as the study was explorative, taking advantage of rich longitudinal data but applying statistical methods that have been developed for other purposes. Thus, there was risk of inflation of type I error, and further larger studies are warranted to validate our findings. Also, no control for confounding was performed.</p><p id="Par55">The study also has several strengths. The main strength is the repeated real-time monitoring of mood and alcohol and nicotine use which yields high-resolution longitudinal data where effects between variables over time can be explored. The mean explained variance among the participants with significant associations is large. The findings are descriptive but can be consistent with causal effects. Also, VAR models are a powerful statistical tool for analysis of multiple parallel time-series and exploration of causal relationships. Lastly, our sample of individuals with BD is catchment-area-based and are included in the early course of BD, thus likely to be representative for the early phase BD population.</p></sec><sec id="Sec14"><title>Conclusion</title><p id="Par56">We found significant temporal relationships between changes in mood and levels of alcohol- and nicotine use in individuals with BD, which provides a basis for hypothesizing that alcohol and nicotine use influence mood levels in BD and vice versa. Future studies should focus on further disentangling these relationships, focusing on differentiating between mood items and individual risk of substance use escalation. Although there are limitations to the clinical generalizability of the results based on the explorative nature of the analyses, they may contribute to a better understanding of the mechanisms of substance use disorder development in BD, which in turn may enhance its prevention and treatment, with potential benefit for the patients.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AUD</term><def><p id="Par5">Alcohol use disorder</p></def></def-item><def-item><term>BD</term><def><p id="Par6">Bipolar disorder</p></def></def-item><def-item><term>CV</term><def><p id="Par7">Clinicians&#x02019; Version</p></def></def-item><def-item><term>FEVD</term><def><p id="Par8">Forecast error variance decomposition</p></def></def-item><def-item><term>MAThyS</term><def><p id="Par9">Multidimensional Assessment of Thymic States</p></def></def-item><def-item><term>NORMENT</term><def><p>Norwegian Center for Mental Disorders Research</p></def></def-item><def-item><term>NOS</term><def><p id="Par10">Not otherwise specified</p></def></def-item><def-item><term>OLS</term><def><p id="Par11">Ordinary least squares</p></def></def-item><def-item><term>OUS</term><def><p id="Par12">Oslo University Hospital</p></def></def-item><def-item><term>SCID</term><def><p id="Par13">Structured Clinical Interview for DSM-IV axis I disorders</p></def></def-item><def-item><term>Std</term><def><p id="Par14">Standard deviation</p></def></def-item><def-item><term>SUD</term><def><p id="Par15">Substance use disorder</p></def></def-item><def-item><term>TUD</term><def><p id="Par16">Tobacco use disorder</p></def></def-item><def-item><term>VAR</term><def><p id="Par17">Vector autoregression model</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to extend a sincere thank you to all the study participants who have dedicated their time and efforts.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>TVL initiated and designed the study with contributions from IM, SRA, RH, TB, BE and RI. SHG, SRA, MJE, SHL, OAA, MCH and TVL collected the data. OK and SHG conducted the data analyses and SHG drafted the manuscript. CB was a lived experience expert involved in the early phases of the study. All authors were involved in critically reviewing the manuscript and have approved the final version.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the Research Council of Norway (Grant Number #288542) and the Health Authority of South-Eastern Norway (Grant Numbers #2007069, 2011033).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The dataset used in the current study are available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par57">The study is conducted in line with the Helsinki declaration of 1975 (as revised in 2008 and 2013) and has been approved by the Regional Committee for Medical Research Ethics and the safety representative of Oslo University Hospital. All participants provided informed consent before entering the study.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par58">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par59">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Baethge</surname><given-names>C</given-names></name><name><surname>Hennen</surname><given-names>J</given-names></name><name><surname>Khalsa</surname><given-names>HM</given-names></name><name><surname>Salvatore</surname><given-names>P</given-names></name><name><surname>Tohen</surname><given-names>M</given-names></name><name><surname>Baldessarini</surname><given-names>RJ</given-names></name></person-group><article-title>Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients</article-title><source>Bipolar Disord</source><year>2008</year><volume>10</volume><issue>6</issue><fpage>738</fpage><lpage>741</lpage><pub-id pub-id-type="doi">10.1111/j.1399-5618.2007.00575.x</pub-id><pub-id pub-id-type="pmid">18837869</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Baethge C, Hennen J, Khalsa HM, Salvatore P, Tohen M, Baldessarini RJ. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord. 2008;10(6):738&#x02013;41. 10.1111/j.1399-5618.2007.00575.x.<pub-id pub-id-type="pmid">18837869</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="book"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A</given-names></name></person-group><source>Co-integration, error correction, and the econometric analysis of non-stationary data</source><year>1993</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name></element-citation><mixed-citation id="mc-CR2" publication-type="book">Banerjee A. Co-integration, error correction, and the econometric analysis of non-stationary data. Oxford: Oxford University Press; 1993.</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Bjella</surname><given-names>TD</given-names></name><name><surname>Collier H&#x000f8;egh</surname><given-names>M</given-names></name><name><surname>Holmstul Olsen</surname><given-names>S</given-names></name><name><surname>Aminoff</surname><given-names>SR</given-names></name><name><surname>Barrett</surname><given-names>E</given-names></name><name><surname>Ueland</surname><given-names>T</given-names></name><name><surname>Icick</surname><given-names>R</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Nerhus</surname><given-names>M</given-names></name><name><surname>Myhre Ihler</surname><given-names>H</given-names></name><name><surname>Hagen</surname><given-names>M</given-names></name><name><surname>Busch-Christensen</surname><given-names>C</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Lagerberg</surname><given-names>TV</given-names></name></person-group><article-title>Developing "MinDag" - an app to capture symptom variation and illness mechanisms in bipolar disorder</article-title><source>Front Med Technol</source><year>2022</year><volume>4</volume><fpage>910533</fpage><pub-id pub-id-type="doi">10.3389/fmedt.2022.910533</pub-id><pub-id pub-id-type="pmid">35935144</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Bjella TD, Collier H&#x000f8;egh M, Holmstul Olsen S, Aminoff SR, Barrett E, Ueland T, Icick R, Andreassen OA, Nerhus M, Myhre Ihler H, Hagen M, Busch-Christensen C, Melle I, Lagerberg TV. Developing &#x0201c;MinDag&#x0201d; - an app to capture symptom variation and illness mechanisms in bipolar disorder. Front Med Technol. 2022;4: 910533. 10.3389/fmedt.2022.910533.<pub-id pub-id-type="pmid">35935144</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Compton</surname><given-names>WM</given-names></name><name><surname>Saha</surname><given-names>TD</given-names></name><name><surname>Goldstein</surname><given-names>BI</given-names></name><name><surname>Ruan</surname><given-names>WJ</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Grant</surname><given-names>BF</given-names></name></person-group><article-title>Epidemiology of DSM-5 bipolar I disorder: results from the National Epidemiologic Survey on alcohol and related conditions - III</article-title><source>J Psychiatr Res</source><year>2017</year><volume>84</volume><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.10.003</pub-id><pub-id pub-id-type="pmid">27814503</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Blanco C, Compton WM, Saha TD, Goldstein BI, Ruan WJ, Huang B, Grant BF. Epidemiology of DSM-5 bipolar I disorder: results from the National Epidemiologic Survey on alcohol and related conditions - III. J Psychiatr Res. 2017;84:310&#x02013;7. 10.1016/j.jpsychires.2016.10.003.<pub-id pub-id-type="pmid">27814503</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Bolton</surname><given-names>JM</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Sareen</surname><given-names>J</given-names></name></person-group><article-title>Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on alcohol and related conditions</article-title><source>J Affect Disord</source><year>2009</year><volume>115</volume><issue>3</issue><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2008.10.003</pub-id><pub-id pub-id-type="pmid">19004504</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on alcohol and related conditions. J Affect Disord. 2009;115(3):367&#x02013;75. 10.1016/j.jad.2008.10.003.<pub-id pub-id-type="pmid">19004504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Canham</surname><given-names>SL</given-names></name><name><surname>Mahmood</surname><given-names>A</given-names></name><name><surname>Stalman</surname><given-names>MN</given-names></name><name><surname>King</surname><given-names>D</given-names></name><name><surname>O'Rourke</surname><given-names>N</given-names></name></person-group><article-title>Personal theories of substance use among middle-aged and older adults with bipolar disorder</article-title><source>Aging Ment Health</source><year>2018</year><volume>22</volume><issue>6</issue><fpage>813</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1080/13607863.2017.1299689</pub-id><pub-id pub-id-type="pmid">28271715</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Canham SL, Mahmood A, Stalman MN, King D, O&#x02019;Rourke N. Personal theories of substance use among middle-aged and older adults with bipolar disorder. Aging Ment Health. 2018;22(6):813&#x02013;8. 10.1080/13607863.2017.1299689.<pub-id pub-id-type="pmid">28271715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>BM</given-names></name><name><surname>Kauer Sant'Anna</surname><given-names>M</given-names></name><name><surname>Dias</surname><given-names>VV</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Ceres&#x000e9;r</surname><given-names>KM</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group><article-title>The impact of co-morbid alcohol use disorder in bipolar patients</article-title><source>Alcohol</source><year>2008</year><volume>42</volume><issue>6</issue><fpage>451</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.alcohol.2008.05.003</pub-id><pub-id pub-id-type="pmid">18760714</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Cardoso BM, Kauer Sant&#x02019;Anna M, Dias VV, Andreazza AC, Ceres&#x000e9;r KM, Kapczinski F. The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol. 2008;42(6):451&#x02013;7. 10.1016/j.alcohol.2008.05.003.<pub-id pub-id-type="pmid">18760714</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Ducasse</surname><given-names>D</given-names></name><name><surname>Jaussent</surname><given-names>I</given-names></name><name><surname>Guillaume</surname><given-names>S</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Belzeaux</surname><given-names>R</given-names></name><name><surname>Bougerol</surname><given-names>T</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Gard</surname><given-names>S</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Kahn</surname><given-names>JP</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><name><surname>Loftus</surname><given-names>J</given-names></name><name><surname>Passerieux</surname><given-names>C</given-names></name><name><surname>Courtet</surname><given-names>PH</given-names></name><name><surname>Oli&#x000e9;</surname><given-names>E</given-names></name></person-group><article-title>Increased risk of suicide attempt in bipolar patients with severe tobacco dependence</article-title><source>J Affect Disord</source><year>2015</year><volume>183</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2015.04.038</pub-id><pub-id pub-id-type="pmid">26001671</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Ducasse D, Jaussent I, Guillaume S, Azorin JM, Bellivier F, Belzeaux R, Bougerol T, Etain B, Gard S, Henry C, Kahn JP, Leboyer M, Loftus J, Passerieux C, Courtet PH, Oli&#x000e9; E. Increased risk of suicide attempt in bipolar patients with severe tobacco dependence. J Affect Disord. 2015;183:113&#x02013;8. 10.1016/j.jad.2015.04.038.<pub-id pub-id-type="pmid">26001671</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Faurholt-Jepsen</surname><given-names>M</given-names></name><name><surname>Munkholm</surname><given-names>K</given-names></name><name><surname>Frost</surname><given-names>M</given-names></name><name><surname>Bardram</surname><given-names>JE</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name></person-group><article-title>Electronic self-monitoring of mood using IT platforms in adult patients with bipolar disorder: a systematic review of the validity and evidence</article-title><source>BMC Psychiatry</source><year>2016</year><volume>16</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/s12888-016-0713-0</pub-id><pub-id pub-id-type="pmid">26769120</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Faurholt-Jepsen M, Munkholm K, Frost M, Bardram JE, Kessing LV. Electronic self-monitoring of mood using IT platforms in adult patients with bipolar disorder: a systematic review of the validity and evidence. BMC Psychiatry. 2016;16:7. 10.1186/s12888-016-0713-0.<pub-id pub-id-type="pmid">26769120</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="book"><person-group person-group-type="author"><name><surname>First</surname><given-names>MB</given-names></name><name><surname>Williams</surname><given-names>JB</given-names></name><name><surname>Karg</surname><given-names>RS</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name></person-group><source>User's guide for the SCID-5-CV structured clinical interview for DSM-5&#x000ae; disorders: clinical version</source><year>2016</year><publisher-loc>Washington</publisher-loc><publisher-name>American Psychiatric Publishing Inc</publisher-name></element-citation><mixed-citation id="mc-CR10" publication-type="book">First MB, Williams JB, Karg RS, Spitzer RL. User&#x02019;s guide for the SCID-5-CV structured clinical interview for DSM-5&#x000ae; disorders: clinical version. Washington: American Psychiatric Publishing Inc; 2016.</mixed-citation></citation-alternatives></ref><ref id="CR11"><mixed-citation publication-type="other">First MB. Structured clinical interview for DSM&#x02010;IV&#x02010;TR axis I disorders, research version, patient edition (SCID&#x02010;I/P). Biometrics research. 2002.</mixed-citation></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Fornaro</surname><given-names>M</given-names></name><name><surname>Carvalho</surname><given-names>AF</given-names></name><name><surname>De Prisco</surname><given-names>M</given-names></name><name><surname>Mondin</surname><given-names>AM</given-names></name><name><surname>Billeci</surname><given-names>M</given-names></name><name><surname>Selby</surname><given-names>P</given-names></name><name><surname>Iasevoli</surname><given-names>F</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Castle</surname><given-names>DJ</given-names></name><name><surname>de Bartolomeis</surname><given-names>A</given-names></name></person-group><article-title>The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: systematic review and meta-analysis</article-title><source>Neurosci Biobehav Rev</source><year>2022</year><volume>132</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2021.11.039</pub-id><pub-id pub-id-type="pmid">34838527</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Fornaro M, Carvalho AF, De Prisco M, Mondin AM, Billeci M, Selby P, Iasevoli F, Berk M, Castle DJ, de Bartolomeis A. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;132:289&#x02013;303. 10.1016/j.neubiorev.2021.11.039.<pub-id pub-id-type="pmid">34838527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Glantz</surname><given-names>MD</given-names></name><name><surname>Bharat</surname><given-names>C</given-names></name><name><surname>Degenhardt</surname><given-names>L</given-names></name><name><surname>Sampson</surname><given-names>NA</given-names></name><name><surname>Scott</surname><given-names>KM</given-names></name><name><surname>Lim</surname><given-names>CCW</given-names></name><name><surname>Al-Hamzawi</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Andrade</surname><given-names>LH</given-names></name><name><surname>Cardoso</surname><given-names>G</given-names></name><name><surname>De Girolamo</surname><given-names>G</given-names></name><name><surname>Gureje</surname><given-names>O</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Hinkov</surname><given-names>H</given-names></name><name><surname>Karam</surname><given-names>EG</given-names></name><name><surname>Karam</surname><given-names>G</given-names></name><name><surname>Kovess-Masfety</surname><given-names>V</given-names></name><name><surname>Lasebikan</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Levinson</surname><given-names>D</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Medina-Mora</surname><given-names>M</given-names></name><name><surname>Mihaescu-Pintia</surname><given-names>C</given-names></name><name><surname>Mneimneh</surname><given-names>Z</given-names></name><name><surname>Moskalewicz</surname><given-names>J</given-names></name><name><surname>Navarro-Mateu</surname><given-names>F</given-names></name><name><surname>Posada-Villa</surname><given-names>J</given-names></name><name><surname>Rapsey</surname><given-names>C</given-names></name><name><surname>Stagnaro</surname><given-names>JC</given-names></name><name><surname>Tachimori</surname><given-names>H</given-names></name><name><surname>Ten Have</surname><given-names>M</given-names></name><name><surname>Tintle</surname><given-names>N</given-names></name><name><surname>Torres</surname><given-names>Y</given-names></name><name><surname>Williams</surname><given-names>DR</given-names></name><name><surname>Ziv</surname><given-names>Y</given-names></name><name><surname>Kessler</surname><given-names>RC</given-names></name></person-group><article-title>The epidemiology of alcohol use disorders cross-nationally: findings from the World Mental Health Surveys</article-title><source>Addict Behav</source><year>2020</year><volume>102</volume><fpage>106128</fpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2019.106128</pub-id><pub-id pub-id-type="pmid">31865172</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Glantz MD, Bharat C, Degenhardt L, Sampson NA, Scott KM, Lim CCW, Al-Hamzawi A, Alonso J, Andrade LH, Cardoso G, De Girolamo G, Gureje O, He Y, Hinkov H, Karam EG, Karam G, Kovess-Masfety V, Lasebikan V, Lee S, Levinson D, McGrath J, Medina-Mora M, Mihaescu-Pintia C, Mneimneh Z, Moskalewicz J, Navarro-Mateu F, Posada-Villa J, Rapsey C, Stagnaro JC, Tachimori H, Ten Have M, Tintle N, Torres Y, Williams DR, Ziv Y, Kessler RC. The epidemiology of alcohol use disorders cross-nationally: findings from the World Mental Health Surveys. Addict Behav. 2020;102: 106128. 10.1016/j.addbeh.2019.106128.<pub-id pub-id-type="pmid">31865172</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Glastad</surname><given-names>SH</given-names></name><name><surname>Aminoff</surname><given-names>SR</given-names></name><name><surname>Hagen</surname><given-names>R</given-names></name><name><surname>H&#x000f8;egh</surname><given-names>MC</given-names></name><name><surname>B&#x000fc;chmann</surname><given-names>CB</given-names></name><name><surname>Barrett</surname><given-names>EA</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Lagerberg</surname><given-names>TV</given-names></name></person-group><article-title>Nicotine use and non-pathological alcohol use and their relationship to affective symptoms and sleep disturbances in bipolar disorder</article-title><source>J Affect Disord</source><year>2023</year><volume>327</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2023.02.003</pub-id><pub-id pub-id-type="pmid">36746243</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Glastad SH, Aminoff SR, Hagen R, H&#x000f8;egh MC, B&#x000fc;chmann CB, Barrett EA, Melle I, Etain B, Lagerberg TV. Nicotine use and non-pathological alcohol use and their relationship to affective symptoms and sleep disturbances in bipolar disorder. J Affect Disord. 2023;327:236&#x02013;43. 10.1016/j.jad.2023.02.003.<pub-id pub-id-type="pmid">36746243</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon-Smith</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>KJS</given-names></name><name><surname>Vallejo Au&#x000f1;&#x000f3;n</surname><given-names>FM</given-names></name><name><surname>Di Florio</surname><given-names>A</given-names></name><name><surname>Perry</surname><given-names>A</given-names></name><name><surname>Craddock</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name></person-group><article-title>Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: findings from the UK Bipolar Disorder Research Network</article-title><source>Bipolar Disord</source><year>2020</year><volume>22</volume><issue>7</issue><fpage>731</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1111/bdi.12905</pub-id><pub-id pub-id-type="pmid">32239612</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Gordon-Smith K, Lewis KJS, Vallejo Au&#x000f1;&#x000f3;n FM, Di Florio A, Perry A, Craddock N, Jones I, Jones L. Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: findings from the UK Bipolar Disorder Research Network. Bipolar Disord. 2020;22(7):731&#x02013;8. 10.1111/bdi.12905.<pub-id pub-id-type="pmid">32239612</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Grande</surname><given-names>I</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Birmaher</surname><given-names>B</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name></person-group><article-title>Bipolar disorder</article-title><source>Lancet</source><year>2016</year><volume>387</volume><issue>10027</issue><fpage>1561</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)00241-X</pub-id><pub-id pub-id-type="pmid">26388529</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561&#x02013;72. 10.1016/S0140-6736(15)00241-X.<pub-id pub-id-type="pmid">26388529</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>G</given-names></name><name><surname>Maruani</surname><given-names>J</given-names></name><name><surname>Vorspan</surname><given-names>F</given-names></name><name><surname>Benard</surname><given-names>V</given-names></name><name><surname>Benizri</surname><given-names>C</given-names></name><name><surname>Brochard</surname><given-names>H</given-names></name><name><surname>Geoffroy</surname><given-names>PA</given-names></name><name><surname>Kahn</surname><given-names>JP</given-names></name><name><surname>Yeim</surname><given-names>S</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name></person-group><article-title>Association between coffee, tobacco, and alcohol daily consumption and sleep/wake cycle: an actigraphy study in euthymic patients with bipolar disorders</article-title><source>Chronobiol Int</source><year>2020</year><volume>37</volume><issue>5</issue><fpage>712</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1080/07420528.2020.1725542</pub-id><pub-id pub-id-type="pmid">32048536</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Gross G, Maruani J, Vorspan F, Benard V, Benizri C, Brochard H, Geoffroy PA, Kahn JP, Yeim S, Leboyer M, Bellivier F, Etain B. Association between coffee, tobacco, and alcohol daily consumption and sleep/wake cycle: an actigraphy study in euthymic patients with bipolar disorders. Chronobiol Int. 2020;37(5):712&#x02013;22. 10.1080/07420528.2020.1725542.<pub-id pub-id-type="pmid">32048536</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>M'Bailara</surname><given-names>K</given-names></name><name><surname>Mathieu</surname><given-names>F</given-names></name><name><surname>Poinsot</surname><given-names>R</given-names></name><name><surname>Falissard</surname><given-names>B</given-names></name></person-group><article-title>Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States)</article-title><source>BMC Psychiatry</source><year>2008</year><volume>8</volume><fpage>82</fpage><pub-id pub-id-type="doi">10.1186/1471-244x-8-82</pub-id><pub-id pub-id-type="pmid">18803831</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Henry C, M&#x02019;Bailara K, Mathieu F, Poinsot R, Falissard B. Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States). BMC Psychiatry. 2008;8:82. 10.1186/1471-244x-8-82.<pub-id pub-id-type="pmid">18803831</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>GE</given-names></name><name><surname>Malhi</surname><given-names>GS</given-names></name><name><surname>Cleary</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>HM</given-names></name><name><surname>Sitharthan</surname><given-names>T</given-names></name></person-group><article-title>Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990&#x02013;2015: systematic review and meta-analysis</article-title><source>J Affect Disord</source><year>2016</year><volume>206</volume><fpage>331</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2016.07.011</pub-id><pub-id pub-id-type="pmid">27476137</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Hunt GE, Malhi GS, Cleary M, Lai HM, Sitharthan T. Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990&#x02013;2015: systematic review and meta-analysis. J Affect Disord. 2016;206:331&#x02013;49. 10.1016/j.jad.2016.07.011.<pub-id pub-id-type="pmid">27476137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Icick</surname><given-names>R</given-names></name><name><surname>Gard</surname><given-names>S</given-names></name><name><surname>Barde</surname><given-names>M</given-names></name><name><surname>Carminati</surname><given-names>M</given-names></name><name><surname>Desage</surname><given-names>A</given-names></name><name><surname>Guillaume</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name></person-group><article-title>Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers</article-title><source>J Affect Disord</source><year>2017</year><volume>208</volume><fpage>406</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2016.09.022</pub-id><pub-id pub-id-type="pmid">27810725</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Icick R, Gard S, Barde M, Carminati M, Desage A, Guillaume S, Scott J, Bellivier F. Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers. J Affect Disord. 2017;208:406&#x02013;13. 10.1016/j.jad.2016.09.022.<pub-id pub-id-type="pmid">27810725</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Icick</surname><given-names>R</given-names></name><name><surname>Gard</surname><given-names>S</given-names></name><name><surname>M'Bailara</surname><given-names>K</given-names></name><name><surname>Biseul</surname><given-names>I</given-names></name><name><surname>Samalin</surname><given-names>L</given-names></name><name><surname>Brousse</surname><given-names>G</given-names></name><name><surname>Flaudias</surname><given-names>V</given-names></name><name><surname>Llorca</surname><given-names>PM</given-names></name><name><surname>Loftus</surname><given-names>J</given-names></name><name><surname>Cussac</surname><given-names>I</given-names></name><name><surname>Aubin</surname><given-names>V</given-names></name><name><surname>Schwan</surname><given-names>R</given-names></name><name><surname>Roux</surname><given-names>P</given-names></name><name><surname>Polosan</surname><given-names>M</given-names></name><name><surname>Courtet</surname><given-names>P</given-names></name><name><surname>Oli&#x000e9;</surname><given-names>E</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Mazer</surname><given-names>N</given-names></name><name><surname>Haffen</surname><given-names>E</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Belzeaux</surname><given-names>R</given-names></name><name><surname>Godin</surname><given-names>O</given-names></name><name><surname>Guillaume</surname><given-names>S</given-names></name></person-group><article-title>The course of bipolar disorder as a function of the presence and sequence of onset of comorbid alcohol use disorders in outpatients attending the Fondamental Advanced Centres of Expertise</article-title><source>J Affect Disord</source><year>2021</year><volume>287</volume><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2021.03.041</pub-id><pub-id pub-id-type="pmid">33799038</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Icick R, Gard S, M&#x02019;Bailara K, Biseul I, Samalin L, Brousse G, Flaudias V, Llorca PM, Loftus J, Cussac I, Aubin V, Schwan R, Roux P, Polosan M, Courtet P, Oli&#x000e9; E, Henry C, Mazer N, Haffen E, Etain B, Leboyer M, Bellivier F, Belzeaux R, Godin O, Guillaume S. The course of bipolar disorder as a function of the presence and sequence of onset of comorbid alcohol use disorders in outpatients attending the Fondamental Advanced Centres of Expertise. J Affect Disord. 2021;287:196&#x02013;203. 10.1016/j.jad.2021.03.041.<pub-id pub-id-type="pmid">33799038</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Khantzian</surname><given-names>EJ</given-names></name></person-group><article-title>The self-medication hypothesis of substance use disorders: a reconsideration and recent applications</article-title><source>Harv Rev Psychiatry</source><year>1997</year><volume>4</volume><issue>5</issue><fpage>231</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.3109/10673229709030550</pub-id><pub-id pub-id-type="pmid">9385000</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231&#x02013;44. 10.3109/10673229709030550.<pub-id pub-id-type="pmid">9385000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagerberg</surname><given-names>TV</given-names></name><name><surname>Aminoff</surname><given-names>SR</given-names></name><name><surname>Aas</surname><given-names>M</given-names></name><name><surname>Bjella</surname><given-names>T</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>G</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Icick</surname><given-names>R</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name></person-group><article-title>Alcohol use disorders are associated with increased affective lability in bipolar disorder</article-title><source>J Affect Disord</source><year>2017</year><volume>208</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2016.09.062</pub-id><pub-id pub-id-type="pmid">27810713</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lagerberg TV, Aminoff SR, Aas M, Bjella T, Henry C, Leboyer M, Pedersen G, Bellivier F, Icick R, Andreassen OA, Etain B, Melle I. Alcohol use disorders are associated with increased affective lability in bipolar disorder. J Affect Disord. 2017;208:316&#x02013;24. 10.1016/j.jad.2016.09.062.<pub-id pub-id-type="pmid">27810713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>N</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Ivanova</surname><given-names>G</given-names></name><name><surname>Hegerl</surname><given-names>U</given-names></name></person-group><article-title>Temporal associations of daily changes in sleep and depression core symptoms in patients suffering from major depressive disorder: idiographic time-series analysis</article-title><source>JMIR Ment Health</source><year>2020</year><volume>7</volume><issue>4</issue><fpage>e17071</fpage><pub-id pub-id-type="doi">10.2196/17071</pub-id><pub-id pub-id-type="pmid">32324147</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Lorenz N, Sander C, Ivanova G, Hegerl U. Temporal associations of daily changes in sleep and depression core symptoms in patients suffering from major depressive disorder: idiographic time-series analysis. JMIR Ment Health. 2020;7(4): e17071. 10.2196/17071.<pub-id pub-id-type="pmid">32324147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="book"><person-group person-group-type="author"><name><surname>L&#x000fc;tkepohl</surname><given-names>H</given-names></name></person-group><source>New introduction to multiple time series analysis</source><year>2005</year><publisher-loc>Berlin</publisher-loc><publisher-name>Springer Science &#x00026; Business Media</publisher-name></element-citation><mixed-citation id="mc-CR25" publication-type="book">L&#x000fc;tkepohl H. New introduction to multiple time series analysis. Berlin: Springer Science &#x00026; Business Media; 2005.</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>JL</given-names></name><name><surname>Meyer</surname><given-names>TD</given-names></name></person-group><article-title>Self-report reasons for alcohol use in bipolar disorders: why drink despite the potential risks?</article-title><source>Clin Psychol Psychother</source><year>2011</year><volume>18</volume><issue>5</issue><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1002/cpp.782</pub-id><pub-id pub-id-type="pmid">21953910</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">McDonald JL, Meyer TD. Self-report reasons for alcohol use in bipolar disorders: why drink despite the potential risks? Clin Psychol Psychother. 2011;18(5):418&#x02013;25. 10.1002/cpp.782.<pub-id pub-id-type="pmid">21953910</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>H</given-names></name><name><surname>Ruud</surname><given-names>T</given-names></name><name><surname>Ravndal</surname><given-names>E</given-names></name><name><surname>Landheim</surname><given-names>A</given-names></name></person-group><article-title>Walking the fine line: self-reported reasons for substance use in persons with severe mental illness</article-title><source>Int J Qual Stud Health Well-Being</source><year>2013</year><volume>8</volume><fpage>21968</fpage><pub-id pub-id-type="doi">10.3402/qhw.v8i0.21968</pub-id><pub-id pub-id-type="pmid">24369778</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Pettersen H, Ruud T, Ravndal E, Landheim A. Walking the fine line: self-reported reasons for substance use in persons with severe mental illness. Int J Qual Stud Health Well-Being. 2013;8:21968. 10.3402/qhw.v8i0.21968.<pub-id pub-id-type="pmid">24369778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Pfaff</surname><given-names>B</given-names></name></person-group><article-title>VAR, SVAR and SVEC models: implementation within R package vars</article-title><source>J Stat Softw</source><year>2008</year><volume>27</volume><issue>4</issue><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.18637/jss.v027.i04</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Pfaff B. VAR, SVAR and SVEC models: implementation within R package vars. J Stat Softw. 2008;27(4):1&#x02013;32.</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>JV</given-names></name><name><surname>Saraf</surname><given-names>G</given-names></name><name><surname>Kozicky</surname><given-names>J</given-names></name><name><surname>Beaulieu</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Parikh</surname><given-names>SV</given-names></name><name><surname>Cervantes</surname><given-names>P</given-names></name><name><surname>Daigneault</surname><given-names>A</given-names></name><name><surname>Walji</surname><given-names>N</given-names></name><name><surname>Kauer-Sant'Anna</surname><given-names>M</given-names></name><name><surname>Yatham</surname><given-names>LN</given-names></name></person-group><article-title>Remission and recurrence in bipolar disorder: The data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study</article-title><source>J Affect Disord</source><year>2020</year><volume>268</volume><fpage>150</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2020.03.018</pub-id><pub-id pub-id-type="pmid">32174473</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Pinto JV, Saraf G, Kozicky J, Beaulieu S, Sharma V, Parikh SV, Cervantes P, Daigneault A, Walji N, Kauer-Sant&#x02019;Anna M, Yatham LN. Remission and recurrence in bipolar disorder: The data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study. J Affect Disord. 2020;268:150&#x02013;7. 10.1016/j.jad.2020.03.018.<pub-id pub-id-type="pmid">32174473</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Preuss</surname><given-names>UW</given-names></name><name><surname>Hesselbrock</surname><given-names>MN</given-names></name><name><surname>Hesselbrock</surname><given-names>VM</given-names></name></person-group><article-title>A prospective comparison of Bipolar I and II subjects with and without comorbid alcohol dependence from the COGA dataset</article-title><source>Front Psychiatry</source><year>2020</year><volume>11</volume><fpage>522228</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2020.522228</pub-id><pub-id pub-id-type="pmid">33408647</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Preuss UW, Hesselbrock MN, Hesselbrock VM. A prospective comparison of Bipolar I and II subjects with and without comorbid alcohol dependence from the COGA dataset. Front Psychiatry. 2020;11: 522228. 10.3389/fpsyt.2020.522228.<pub-id pub-id-type="pmid">33408647</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Rakofsky</surname><given-names>JJ</given-names></name><name><surname>Dunlop</surname><given-names>BW</given-names></name></person-group><article-title>Do alcohol use disorders destabilize the course of bipolar disorder?</article-title><source>J Affect Disord</source><year>2013</year><volume>145</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2012.06.012</pub-id><pub-id pub-id-type="pmid">22858208</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Rakofsky JJ, Dunlop BW. Do alcohol use disorders destabilize the course of bipolar disorder? J Affect Disord. 2013;145(1):1&#x02013;10. 10.1016/j.jad.2012.06.012.<pub-id pub-id-type="pmid">22858208</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f8;devand</surname><given-names>L</given-names></name><name><surname>Steen</surname><given-names>NE</given-names></name><name><surname>Elvs&#x000e5;shagen</surname><given-names>T</given-names></name><name><surname>Quintana</surname><given-names>DS</given-names></name><name><surname>Reponen</surname><given-names>EJ</given-names></name><name><surname>M&#x000f8;rch</surname><given-names>RH</given-names></name><name><surname>Lunding</surname><given-names>SH</given-names></name><name><surname>Vedal</surname><given-names>TSJ</given-names></name><name><surname>Dieset</surname><given-names>I</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Lagerberg</surname><given-names>TV</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name></person-group><article-title>Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade</article-title><source>Acta Psychiatr Scand</source><year>2019</year><volume>139</volume><issue>4</issue><fpage>348</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1111/acps.13008</pub-id><pub-id pub-id-type="pmid">30697685</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">R&#x000f8;devand L, Steen NE, Elvs&#x000e5;shagen T, Quintana DS, Reponen EJ, M&#x000f8;rch RH, Lunding SH, Vedal TSJ, Dieset I, Melle I, Lagerberg TV, Andreassen OA. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade. Acta Psychiatr Scand. 2019;139(4):348&#x02013;60. 10.1111/acps.13008.<pub-id pub-id-type="pmid">30697685</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>SE</given-names></name><name><surname>Dickey</surname><given-names>DA</given-names></name></person-group><article-title>Testing for unit roots in autoregressive-moving average models of unknown order</article-title><source>Biometrika</source><year>1984</year><volume>71</volume><issue>3</issue><fpage>599</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1093/biomet/71.3.599</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Said SE, Dickey DA. Testing for unit roots in autoregressive-moving average models of unknown order. Biometrika. 1984;71(3):599&#x02013;607. 10.1093/biomet/71.3.599.</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="book"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name></person-group><source>Neurobiology of alcohol and the brain</source><year>2021</year><publisher-loc>Cambridge</publisher-loc><publisher-name>Academic Press</publisher-name></element-citation><mixed-citation id="mc-CR34" publication-type="book">Singh A. Neurobiology of alcohol and the brain. Cambridge: Academic Press; 2021.</mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Tondo</surname><given-names>L</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>GH</given-names></name><name><surname>Baldessarini</surname><given-names>RJ</given-names></name></person-group><article-title>Depression and mania in bipolar disorder</article-title><source>Curr Neuropharmacol</source><year>2017</year><volume>15</volume><issue>3</issue><fpage>353</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.2174/1570159x14666160606210811</pub-id><pub-id pub-id-type="pmid">28503106</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Tondo L, V&#x000e1;zquez GH, Baldessarini RJ. Depression and mania in bipolar disorder. Curr Neuropharmacol. 2017;15(3):353&#x02013;8. 10.2174/1570159x14666160606210811.<pub-id pub-id-type="pmid">28503106</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>van Zaane</surname><given-names>J</given-names></name><name><surname>van de Ven</surname><given-names>PM</given-names></name><name><surname>Draisma</surname><given-names>S</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Nolen</surname><given-names>WA</given-names></name><name><surname>van den Brink</surname><given-names>W</given-names></name></person-group><article-title>Effect of alcohol use on the course of bipolar disorder: one-year follow-up study using the daily prospective Life Chart method</article-title><source>Bipolar Disord</source><year>2014</year><volume>16</volume><issue>4</issue><fpage>400</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1111/bdi.12191</pub-id><pub-id pub-id-type="pmid">24673879</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">van Zaane J, van de Ven PM, Draisma S, Smit JH, Nolen WA, van den Brink W. Effect of alcohol use on the course of bipolar disorder: one-year follow-up study using the daily prospective Life Chart method. Bipolar Disord. 2014;16(4):400&#x02013;9. 10.1111/bdi.12191.<pub-id pub-id-type="pmid">24673879</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Wilens</surname><given-names>TE</given-names></name><name><surname>Martelon</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>JP</given-names></name><name><surname>Shelley-Abrahamson</surname><given-names>R</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name></person-group><article-title>Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents</article-title><source>Drug Alcohol Depend</source><year>2013</year><volume>132</volume><issue>1&#x02013;2</issue><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2013.01.015</pub-id><pub-id pub-id-type="pmid">23422834</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wilens TE, Martelon M, Anderson JP, Shelley-Abrahamson R, Biederman J. Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents. Drug Alcohol Depend. 2013;132(1&#x02013;2):114&#x02013;21. 10.1016/j.drugalcdep.2013.01.015.<pub-id pub-id-type="pmid">23422834</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Wittenberg</surname><given-names>RE</given-names></name><name><surname>Wolfman</surname><given-names>SL</given-names></name><name><surname>De Biasi</surname><given-names>M</given-names></name><name><surname>Dani</surname><given-names>JA</given-names></name></person-group><article-title>Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction</article-title><source>Neuropharmacology</source><year>2020</year><volume>177</volume><fpage>108256</fpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2020.108256</pub-id><pub-id pub-id-type="pmid">32738308</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Wittenberg RE, Wolfman SL, De Biasi M, Dani JA. Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction. Neuropharmacology. 2020;177: 108256. 10.1016/j.neuropharm.2020.108256.<pub-id pub-id-type="pmid">32738308</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>